Accessibility Information

Users of assistive technologies such as screen readers should use the following link to activate Accessibility Mode before continuing: Learn more and Activate accessibility mode.

A -- Advanced Development of New Antiviral Agents for Influenza

Solicitation Number: DHHS-ORDC-VB-06-01
Agency: Department of Health and Human Services
Office: Office of the Secretary
Location: Assistant Secretary for Preparedness and Response
  • Print

Opportunity History
:
DHHS-ORDC-VB-06-01
:
Award
:
January 3, 2007
:
HHSO100200700032C
:
102,661,429
:
BioCryst Pharmaceuticals Inc.2190 Parkway Lake Drive
Birmingham, AL 35244
:
Added: May 15, 2006 Modified: January 4, 2007Track Changes
No Description Provided
:
Department of Health and Human Services, Office of the Secretary, Office of Public Health Emergency Preparedness, Office of Public Health Emergency Medical Countermeasures 330 Independence Avenue, SW, Rm G640, Washington, DC, 20201, UNITED STATES
:
Schuyler Eldridge, Contracting Officer, Phone 202-205-3976, Fax 202-205-4520, Email schuyler.eldridge@hhs.gov - Earlene Bedford, Contract Specialist, Phone 202-205-3977, Fax 202-205-6092, Email earlene.bedford@hhs.gov

General Information

Notice Type:
Award
Original Posted Date:
May 15, 2006
Posted Date:
January 4, 2007
Response Date:
-
Original Response Date:
July 18, 2006
Archiving Policy:
Automatic, on specified date
Archive Date:
March 30, 2007
Original Set Aside:
N/A
Set Aside:
N/A
Classification Code:
A -- Research & Development
NAICS Code:
325 -- Chemical Manufacturing/325414 -- Biological Product (except Diagnostic) Manufacturing